论文部分内容阅读
冠心病和肿瘤并存的情况越来越常见。肿瘤本身及其治疗影响冠状动脉介入术(PCI)的安全性,PCI术后的二联抗血小板治疗也影响肿瘤的手术治疗。因此,肿瘤患者应尽量避免PCI。肿瘤手术前是否进行预防性PCI取决于术前心脏风险评估的结果。PCI只适用于冠状动脉病变严重或不稳定的肿瘤患者,治疗方式应优选单纯球囊扩张或植入金属裸支架。
Coronary heart disease and cancer coexist more and more common. Tumor itself and its treatment affect the safety of coronary artery surgery (PCI), PCI antiplatelet therapy also affects the surgical treatment of tumors. Therefore, cancer patients should try to avoid PCI. Prophylactic PCI before tumor surgery depends on the results of preoperative cardiac risk assessment. PCI only applies to patients with severe or unstable coronary artery disease, the treatment should be preferred balloon dilation or implantation of bare metal stent.